Current share price for AVR : $15.000 1.37 (10.05%)+
Anteris Technologies Ltd (AVR), an ASX-listed company, is a structural heart company focused on designing, developing, and commercialising medical devices. Founded in Australia, with a presence in Minneapolis, USA (a MedTech hub), it is science-driven, with a team of professionals delivering solutions to structural heart disease patients.
| ASX Code | AVR |
| Website | http://www.anteristech.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 228 |
| AVR Share Price | $15.000 |
| Day High | $15.000 |
| Day Low | $14.450 |
| Last Close | $13.630 |
| AVR Share Price Movement | $1.37 ( 10.05% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Interim | 6¢ | 0% | 2 Mar 2007 | 22 Mar 2007 | - | - | - |
| Final | 5¢ | 100% | 8 Sep 2006 | 25 Sep 2006 | - | - | - |
| Interim | 3.5¢ | 100% | 1 Mar 2006 | 21 Mar 2006 | - | - | - |
See all dividends from Anteris Technologies Ltd (AVR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Dec | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$140.78 | -$381.10 | -36.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$120.74 | -$598.70 | 38.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$68.89 | -$431.50 | 30.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Anteris Technologies Ltd (AVR) | $207M | -0.3635 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Cochlear Limited (COH) | $7,376M | 0.0171 | -0.1883 | 0.0862 | 18.8460 | 23.2177 | 21.3760 | 3.81% | 3.07% | 3.28% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $18,124M | 0.1388 | 0.1362 | 0.1883 | 46.6657 | 41.0700 | 34.5615 | 1.41% | 1.50% | 1.70% |
| ResMed Inc. (RMD) | $15,444M | 0.3087 | 9.7634 | 0.0805 | 185.9697 | 17.2780 | 15.9905 | 1.24% | 1.30% | 1.37% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -4,545.00 | 0.00 |
| Market | 0.29 | 13.20 | 1.16 | 0.69 |
| Sector | 0.57 | 20.50 | 1.61 | 2.49 |
| Name | Position | Start Date |
|---|---|---|
| Mr Wayne Paterson | Chief Executive Officer, Managing Director | 29 Jan 2024 |
| Mr David St Denis | Chief Operating Officer, President, Non-Executive director | 6 Mar 2025 |
| Mr Gregory Simon Moss | Class I Director, Non-Executive Director | 8 Jun 2025 |
| Mr David Roberts | Class III Director, Non-Executive Director | 8 Jun 2025 |
| Mr Stephen (Steve) Denaro | Company Secretary, Non Executive Director | 12 May 2026 |
| Mr John Seaberg | Non-Executive Chairman, Non-Executive Director | 13 Nov 2024 |
| Ms Susan Knight | Non-Executive Director | 12 May 2026 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 2 Jun 2026 | KNIGHT, Susan | Buy | Direct Shares | 11,000 | $9.293 | $102,228.200 |
| 31 May 2023 | PATERSON, Wayne | Issued | Direct Shares | 4,167 | $24.000 | $100,008.000 |
| 7 Mar 2022 | DENARO, Stephen (Steve) | Buy | Indirect Shares | 2,222 | $18.020 | $40,039.970 |
See all changes in directors' interest & trades for Anteris Technologies Ltd (AVR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Date | Event |
|---|---|
| 26 February 2027 | Report (Annual) |
| 26 February 2027 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.